Skip to main content
Equibles
TMDX logo

TMDX · TransMedics Group, Inc. · Webcasts, Transcripts & Audio

Track TMDX — free

Use TMDX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TMDX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$65.99 -1.13 (-1.68%) At close · Oct 30 Q1 2026 earnings call transcript
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.29B
Shares
34.68M
Volume · Oct 30 900.11K Avg daily vol (3M) 835.12K

TransMedics Group, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for TransMedics Group, Inc. (TMDX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Conference
Investor event
2026-12-01
TransMedics Group, Inc. (TMDX) December 1, 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-11-17
TransMedics Group, Inc. (TMDX) November 17, 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-11-10
TransMedics Group, Inc. (TMDX) November 10, 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q3
2026-11-05
TransMedics Group, Inc. (TMDX) Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-09-15
TransMedics Group, Inc. (TMDX) September 15, 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-14
TransMedics Group, Inc. (TMDX) September 14, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-08-11
TransMedics Group, Inc. (TMDX) August 11, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-04
TransMedics Group, Inc. (TMDX) Q2 2026 Earnings Call
Revenue
$189.95M
▲ 20.7% YoY
Diluted EPS
$0.41
▼ 55.4% YoY
Gross margin
59.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-02
TransMedics Group, Inc. (TMDX) June 2, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-05
TransMedics Group, Inc. (TMDX) Q1 2026 Earnings Call Transcript
Confident tone ENHANCE Heart and DENOVO Lung Trials CHOPS Cold Storage Device Full-Year Revenue Guidance
Revenue
$173.93M
▲ 21.2% YoY
Diluted EPS
$0.20
▼ 71.4% YoY
Gross margin
58.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
TransMedics Group, Inc. (TMDX) Q4 2025 Earnings Call Transcript
Confident tone 2026 Margin / Investment Guidance OPO / CMS Regulatory Landscape ENHANCE Heart and DENOVO Lung Clinical Programs
Revenue
$160.76M*
▲ 32.2% YoY
Gross margin
58.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-29
TransMedics Group, Inc. (TMDX) Q3 2025 Earnings Call Transcript
Confident tone Competitive Landscape / OrganOx Acquisition International / Italy NOP Expansion Seasonality and Market Softness
Revenue
$143.82M
▲ 32.2% YoY
Diluted EPS
$0.66
▲ 450% YoY
Gross margin
58.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-30
TransMedics Group, Inc. (TMDX) Q2 2025 Earnings Call Transcript
Confident tone Summer seasonality and Q3 outlook / guidance National Transplant Modernization initiative and tariffs Kidney OCS platform and international NOP expansion
Revenue
$157.37M
▲ 37.7% YoY
Diluted EPS
$0.92
▲ 162.9% YoY
Gross margin
61.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
TransMedics Group, Inc. (TMDX) Q1 2025 Earnings Call Transcript
Confident tone OCS NOP Commercial Growth Next-Gen OCS Heart and Lung Clinical Programs 2025 Outlook and Guidance
Revenue
$143.54M
▲ 48.2% YoY
Diluted EPS
$0.70
▲ 100% YoY
Gross margin
61.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
TransMedics Group, Inc. (TMDX) Q4 2024 Earnings Call Transcript
Confident tone Q4 and Full Year 2024 Results 2025 Financial Guidance Transplant Logistics / Aviation Fleet Expansion
Revenue
$121.62M*
▲ 49.8% YoY
Gross margin
59.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-28
TransMedics Group, Inc. (TMDX) Q3 2024 Earnings Call Transcript
Positive tone Revenue growth and mix (U.S. vs OUS) Competitive dynamics (NRP) and pricing International / OUS expansion
Revenue
$108.76M
▲ 63.7% YoY
Diluted EPS
$0.12
Gross margin
55.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-31
TransMedics Group, Inc. (TMDX) Q2 2024 Earnings Call Transcript
Confident tone Revenue Growth and Financial Performance Transplant Logistics Network Expansion Clinical Pipeline (Lung and Heart Programs)
Revenue
$114.31M
▲ 117.9% YoY
Diluted EPS
$0.35
Gross margin
60.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-04-30
TransMedics Group, Inc. (TMDX) Q1 2024 Earnings Call Transcript
Confident tone NOP and transplant logistics / aviation fleet OCS clinical programs and pipeline Revenue growth and guidance raise
Revenue
$96.85M
▲ 133.1% YoY
Diluted EPS
$0.35
Gross margin
61.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-26
TransMedics Group, Inc. (TMDX) Q4 2023 Earnings Call Transcript
Confident tone National OCS transplant program (NOP) TransMedics logistics services Gross margin trajectory
Revenue
$81.17M*
▲ 158.7% YoY
Gross margin
59.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-06
TransMedics Group, Inc. (TMDX) Q3 2023 Earnings Call Transcript
Revenue
$66.43M
▲ 158.7% YoY
Diluted EPS
$-0.78
Gross margin
61.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
TransMedics Group, Inc. (TMDX) Q2 2023 Earnings Call Transcript
Revenue
$52.47M
▲ 155.7% YoY
Diluted EPS
$-0.03
Gross margin
70.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-01
TransMedics Group, Inc. (TMDX) Q1 2023 Earnings Call Transcript
Revenue
$41.55M
▲ 161.7% YoY
Diluted EPS
$-0.08
Gross margin
69.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-22
TransMedics Group, Inc. (TMDX) Q4 2022 Earnings Call Transcript
Revenue
$31.38M*
▲ 224.5% YoY
Gross margin
66.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-03
TransMedics Group, Inc. (TMDX) Q3 2022 Earnings Call Transcript
Revenue
$25.68M
▲ 378.3% YoY
Diluted EPS
$-0.25
Gross margin
70.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-01
TransMedics Group, Inc. (TMDX) Q2 2022 Earnings Call Transcript
Revenue
$20.52M
▲ 151.1% YoY
Diluted EPS
$-0.41
Gross margin
69.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-03
TransMedics Group, Inc. (TMDX) Q1 2022 Earnings Call Transcript
Revenue
$15.88M
▲ 125.2% YoY
Diluted EPS
$-0.38
Gross margin
76.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
TransMedics Group, Inc. (TMDX) Q4 2021 Earnings Call Transcript
Revenue
$9.67M*
▲ 26.8% YoY
Gross margin
72.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-09
TransMedics Group, Inc. (TMDX) Q3 2021 Earnings Call Transcript
Revenue
$5.37M
▼ 24.3% YoY
Diluted EPS
$-0.47
Gross margin
70.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
TransMedics Group, Inc. (TMDX) Q2 2021 Earnings Call Transcript
Revenue
$8.17M
▲ 141% YoY
Diluted EPS
$-0.39
Gross margin
68.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
TransMedics Group, Inc. (TMDX) Q1 2021 Earnings Call Transcript
Revenue
$7.05M
▼ 6.3% YoY
Diluted EPS
$-0.29
Gross margin
68.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-02
TransMedics Group, Inc. (TMDX) Q4 2020 Earnings Call Transcript
Revenue
$7.63M
▲ 25.9% YoY
Gross margin
63.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-04
TransMedics Group, Inc. (TMDX) Q3 2020 Earnings Call Transcript
Revenue
$7.09M
▼ 1.6% YoY
Diluted EPS
$-0.19
Gross margin
71.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
TransMedics Group, Inc. (TMDX) Q2 2020 Earnings Call Transcript
Revenue
$3.39M
▼ 40.2% YoY
Diluted EPS
$-0.36
Gross margin
56.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-13
TransMedics Group, Inc. (TMDX) Q1 2020 Earnings Call Transcript
Revenue
$7.53M
▲ 61% YoY
Diluted EPS
$-0.42
Gross margin
64.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-04
TransMedics Group, Inc. (TMDX) Q4 2019 Earnings Call
Revenue
$6.06M
▲ 70.9% YoY
Gross margin
61.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–35 of 35 webcasts
Key facts CIK 1756262 CUSIP 89377M109 13F (30d) 121 filings 110 filers Visit website Investor relations